ArticleBMC bioinformatics2026
A weight-sharing Bayesian neural network for consistent feature selection with applications in cancer gene expression data.
Article in BMC bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A weight-sharing Bayesian neural network for consistent feature selection with applications in cancer gene expression data.BMC bioinformatics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAdvances in sequencing technologies generate extensive genetic information. Datasets such as the Cancer Genome Atlas (TCGA) BRCA facilitate large-scale cancer gene expression analyses, providing insights into the molecular mechanisms driving tumor progression. Effective feature selection—identifying cancer or its subtype-related genes from expression profiles—is critical, as it enhances diagnostic accuracy and guides personalized therapies. However, feature selection is hindered by dimensionality, low sample sizes, and nonlinear interactions within the data, making traditional models, including LASSO and its Bayesian counterparts, inadequate for interpretable feature selection. We thus propose a novel weight-sharing Bayesian neural network (wsBNN) leveraging shared spike-and-slab priors within a neural network framework to enable adaptive weight shrinkage for efficient and interpretable feature selection.
resultsWe incorporate a scalable variational Bayes inference embedded in backpropagation while ensuring effective feature selection. Studying the theoretical properties of the variational posterior shows insights into the performance and theoretical guarantees of wsBNN. Both simulated and real-world dataset experiments show that wsBNN surpasses state-of-the-art nonlinear methods, including frequentist neural networks, in terms of predictive performance and consistency in feature selection. Furthermore, it competes well with classical methods such as Random Forests and Gradient Boosting. TCGA BRCA data study highlights wsBNN’s practical applicability in identifying key biomarkers, particularly in Breast Cancer analysis. The model effectively captured cancer-associated genes and pathways—particularly those related to ERBB2 and PI3K/AKT signaling, immune regulation, and cell cycle control—showing superior biological relevance and interpretability compared to baseline methods.
conclusionsOur findings—e.g., consistently identifying relevant biomarkers—position wsBNN as a promising approach for feature selection in high-dimensional genomic datasets and show its potential to advance precision medicine. By integrating weight-grouping with shared spike-and-slab priors within a Bayesian neural network, wsBNN effectively balances sparsity, interpretability, and scalability. wsBNN’s ability to recover biologically relevant genes and pathways highlights its importance for interpretable genomic analysis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.